FDA Inspection 1064927 — Hdh Pharma Inc
The FDA completed an inspection of Hdh Pharma Inc on Jul 23, 2018 in Morrisville, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 23, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Morrisville, NC (United States)